Genetic risk factors idiopathic thrombocytopenic purpura following measles mumps rubella vaccination in children
Ended Awarded Last action
- Contract number
- HHSF22301006T
- Awardee
-
Harvard Pilgrim Health Care, Inc. UEI NZVVQ8GNVX65
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $546,714
Award facts
- Contract value 100% obligated
- $546,714.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541690 Other Scientific and Technical Consulting Services
- PSC
- C118 Research And Development Facilities
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Wellesley Hills, Wellesley, MA 02481, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$21,665 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $568,379 |
About this award
This is a $546,714.33 cost-plus-fixed-fee delivery order contract awarded by the Food and Drug Administration (FDA) to Harvard Pilgrim Health Care Inc.'s Office of Sponsored Programs Division, a non-profit healthcare research organization. The contract supports research on genetic risk factors for idiopathic thrombocytopenic purpura following measles, mumps, and rubella vaccination in children.
The contract is not set aside and is part of Harvard Pilgrim's extensive portfolio of federal contracts and grants, including several multi-million dollar Indefinite Delivery/Indefinite Quantity (IDIQ) contracts with the FDA and Centers for Disease Control and Prevention (CDC) to provide data analytics, pharmacoepidemiology, and public health research services. This includes supporting major initiatives like the Sentinel System for post-market medical product safety monitoring and the Vaccine Safety Datalink. Harvard Pilgrim frequently collaborates with other academic institutions on federally-funded research projects across multiple NIH institutes.
Quick answers
Who was awarded contract HHSF22301006T?
HHSF22301006T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 9, 2010.
How much is contract HHSF22301006T worth?
The government has obligated $546,714 on HHSF22301006T.
Is contract HHSF22301006T an order under another contract?
Yes. HHSF22301006T is a delivery order under HHSF223200810026I, an indefinite delivery contract.
Was contract HHSF22301006T competed?
The extent of competition for HHSF22301006T was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award